Immunological responsiveness against two primary antigens in untreated patients with Hodgkin's disease.
D000293:Adolescent; D000328:Adult; D000917:Antibody Formation; D002986:Clinical Trials as Topic; D004137:Dinitrochlorobenzene / Q000276:immunology; D005260:Female; D006388:Hemagglutinins / Q000032:analysis; D006433:Hemocyanins / Q000276:immunology; D006689:Hodgkin Disease / Q000276:immunology / Q000473:pathology; D006801:Humans; D007111:Immunity, Cellular; D007074:Immunoglobulin G / Q000032:analysis; D007075:Immunoglobulin M / Q000032:analysis; D037102:Lectins / Q000494:pharmacology; D008213:Lymphocyte Activation; D008297:Male; D008623:Mercaptoethanol; D008875:Middle Aged; D012882:Skin Tests
D004137:Dinitrochlorobenzene; D006388:Hemagglutinins; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D037102:Lectins; D008623:Mercaptoethanol; D006433:Hemocyanins